Abstract

<p>Excessive adiposity is the main cause of obesity and type two diabetes (T2D). Variants in human IMP2/IGF2BP2 gene are associated with increased risk of T2D. However, little is known about its role in adipogenesis and in insulin resistance. Here, we investigate the function of IMP2 during adipocyte development. Mice with IMP2 deletion in mesenchymal stem cells (MSCs) are resistant to diet-induced obesity without affecting glucose and insulin tolerance. IMP2 is essential for the early commitment of adipocyte derived stem cells (ADSCs) into preadipocytes; but the deletion of IMP2 in MSCs is not required for the proliferation and terminal differentiation of committed preadipocytes. Mechanistically, IMP2 binds Wnt receptor FDZ8 mRNA and promotes its degradation by recruiting <a href="https://www.nature.com/articles/ncomms12626?origin=ppub" target="_blank">CCR4–NOT deadenylase complex</a> in a mTOR dependent manner. Our data demonstrate that IMP2 is required for maintaining white adipose tissue (WAT) homeostasis by controlling mRNA stability in ADSCs. However, the contribution of IMP2 to insulin resistance, a main risk of T2D, is not evident.</p>

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.